Bioauxilium specializes in the design, development and manufacturing of ready-to-use TR-FRET assay kits that simplify laboratory workflow and accelerate drug discovery and life sciences research.
An increasing number of pharma and biotech companies, as well as CROs and academic laboratories, are adopting BioAuxilium’s THUNDER™ TR-FRET assay platform to quantify key human cytokines in cell supernatants. Based on customer feedback, there are 3 key reasons. Reason #1: High performance assays THUNDER™ Human Cytokine Assay Kits are designed to measure key human […]See more
In the framework of our ongoing strategic collaboration with BMG LABTECH, we have evaluated the performance of a panel of three THUNDER™ TR-FRET phospho-proteins assays and five human cytokine assays on the flexible and powerful CLARIOstar® Plus multi-mode microplate reader. The results, summarized in the Application Note 361 and in a tutorial showed an excellent assay […]See more
As part of our ongoing strategic collaboration with BMG LABTECH, we have recently evaluated the performance of a panel of five THUNDER™ TR-FRET human cytokine assays on the top-of-the-line PHERAstar® FSX multi-mode microplate reader. The results, summarized in the Application Note 365, showed a superb assay performance of our assays on this HTS instrument. Figure 1: THUNDER™ […]See more
At the annual SLAS International Conference and Exhibition in Boston, we announced the expansion of our no-wash THUNDER™ time-resolved Förster resonance energy transfer (TR-FRET) technology portfolio by introducing new cell signaling pathway and biomarker research assay kits, along with a panel of “mix and match” toolbox reagents. The new offerings bring our portfolio to a total […]See more
BioAuxilium has published an article in the J Vis Exp (JoVE) Journal (Biochemistry). In this paper, we describe in detail protocols for the simple, sensitive, robust, and cost-effective measurement in a 384-well format of endogenous phosphorylated STAT1/3/4/5/6 proteins, together with total STAT1/3/5/6, in cell lysates using the THUNDER™ TR-FRET platform. In brief: We measured the […]See more
Bioauxilium has initiated strategic collaborations with leading developers of microplate detection instruments to demonstrate the compatibility of its increasingly popular THUNDER™ TR-FRET assay platform with select high-value multimode microplate readers under real assay conditions. BioTek® has recently evaluated the performance of the THUNDER™ Phospho-AKT pan (S473) TR-FRET Cell Signaling Assay Kit on the Synergy™ Neo2 […]See more
Bioauxilium is proud to announce the publication of an Application Note describing for the first time a comparison among three commercial TR-FRET assay platforms for measuring endogenous phosphoproteins in cellular lysates. The results of this head-to-head study demonstrate superior or comparable performance of THUNDER™ Cell Signaling Assays Kits to that of two existing TR‑FRET platforms […]See more